Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 15 Dec 2022

Investigation of M2 macrophage-related gene affecting patients prognosis and drug sensitivity in non-small cell lung cancer: Evidence from bioinformatic and experiments

in Thoracic Oncology

Zhen Zeng
Jiachen Yu
Zhuo Yang
Kangming Du
Yuewei Chen
Lei Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.1096449

4,084 views
12 citations

Clinical Trial

Published on 15 Dec 2022

Study protocol of an open-label prospective phase II umbrella study of precise neoadjuvant therapy for patients with stage II-IIIB resectable non-small cell lung cancer (PURPOSE)

in Thoracic Oncology

Yiyang Wang
Haoran Zhai
Jiaming Wang
Teng Mao
Chunyu Ji
Feichao Bao
Zhitao Gu
Wentao Fang

Frontiers in Oncology

doi 10.3389/fonc.2022.1052774

4,071 views
3 citations

Original Research

Published on 15 Dec 2022

Whole exome sequencing in Chinese mucinous pulmonary adenocarcinoma uncovers specific genetic variations different from lung adenocarcinoma

in Thoracic Oncology

Chenyue Zhang
Kai Wang
Wenjie Liu
Jiamao Lin
Zhenxiang Li
Hui Wang
Chenglong Zhao
Yanhua Chen
Shuangxiu Wu
Airong Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.1054845

2,920 views
1 citation

Case Report

Published on 15 Dec 2022

Case report: Liquid biopsy, the sooner the better?

in Thoracic Oncology

Quentin Dominique Thomas
Julien Colard-Thomas
Delphine Delansay
Fanny Leenhardt
Jerome Solassol
Julie A. Vendrell
Xavier Quantin

Frontiers in Oncology

doi 10.3389/fonc.2022.1089108

3,260 views
4 citations

Correction

Published on 15 Dec 2022

Corrigendum: Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis

in Thoracic Oncology

Wei Zhang
Weiwei Wang
Junlu Wu
Jiale Tian
Wenhui Yan
Yi Yuan
Yiwen Yao
Anquan Shang
Wenqiang Quan

Frontiers in Oncology

doi 10.3389/fonc.2022.1118042

1,569 views

Review

Published on 14 Dec 2022

Metabolic targeting, immunotherapy and radiation in locally advanced non-small cell lung cancer: Where do we go from here?

in Thoracic Oncology

Annika Dhawan
Phillip M. Pifer
Vlad C. Sandulache
Heath D. Skinner

Frontiers in Oncology

doi 10.3389/fonc.2022.1016217

5,267 views
6 citations

Clinical Trial

Published on 14 Dec 2022

Low-dose computed tomography for lung cancer screening in Anhui, China: A randomized controlled trial

in Thoracic Oncology

Feng Rong
Rui Shi
Lili Hu
Ran Chen
Daoyue Wang
Xiazhi Lv
Yong Zhao
Wei Huang
Yang Yang
Hongyang Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.1059999

3,428 views
5 citations

Original Research

Published on 14 Dec 2022

Next-generation sequencing of homologous recombination genes could predict efficacy of platinum-based chemotherapy in non-small cell lung cancer

in Thoracic Oncology

Linlin Zhang
Shasha Guan
Fanlu Meng
Lin Teng
Diansheng Zhong

Frontiers in Oncology

doi 10.3389/fonc.2022.1035808

3,549 views
5 citations

Systematic Review

Published on 14 Dec 2022

Current status and challenges of immunotherapy in ALK rearranged NSCLC

in Thoracic Oncology

Rongbin Qi
Yingying Yu
Mo Shen
Dongqing Lv
Susu He

Frontiers in Oncology

doi 10.3389/fonc.2022.1016869

5,013 views
8 citations

Case Report

Published on 14 Dec 2022

Case Report: Bronchial artery embolization and chemoradiotherapy for central squamous cell lung carcinoma with rapid regression

in Thoracic Oncology

Siqi Zhou
Jianxin Zhang
Xue Meng
Yingtao Meng
Xiao Han

Frontiers in Oncology

doi 10.3389/fonc.2022.1026087

2,399 views
1 citation

Correction

Published on 13 Dec 2022

Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy

in Thoracic Oncology

Ni Zhao
Ye Yi
Wen Cao
Xiao Fu
Nan Mei
Chunli Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1069999

1,543 views
9 citations

Original Research

Published on 13 Dec 2022

Economic evaluation of first-line sugemalimab plus chemotherapy for metastatic non-small cell lung cancer in China

in Thoracic Oncology

Hao Wang
Li Liao
Yuan Xu
Yunchun Long
Ye Wang
Yujie Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.1081750

3,406 views
4 citations

Correction

Published on 13 Dec 2022

Corrigendum: Long non-coding RNA-TMPO-AS1 as ceRNA binding to let-7c-5p upregulates STRIP2 expression and predicts poor prognosis in lung adenocarcinoma

in Thoracic Oncology

Juan Wang
Yixiao Yuan
Lin Tang
Haoqing Zhai
Dahang Zhang
Lincan Duan
Xiulin Jiang
Chen Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1109637

1,679 views
9 citations

Editorial

Published on 12 Dec 2022

Editorial: Long non-coding RNAs in lung cancer

in Thoracic Oncology

Umberto Malapelle
Giulia Veronesi

Frontiers in Oncology

doi 10.3389/fonc.2022.1100061

1,261 views

Review

Published on 08 Dec 2022

The natural growth history of persistent pulmonary subsolid nodules: Radiology, genetics, and clinical management

in Thoracic Oncology

Zhedong Zhang
Lixin Zhou
Fan Yang
Xiao Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1011712

7,203 views
7 citations

Mini Review

Published on 08 Dec 2022

Current and novel therapeutic strategies for optimizing immunotherapy outcomes in advanced non-small cell lung cancer

in Thoracic Oncology

Claudio Martin
Diego Enrico

Frontiers in Oncology

doi 10.3389/fonc.2022.962947

3,662 views
9 citations

Original Research

Published on 08 Dec 2022

Changes in lung cancer-related serum tumor markers in patients with chronic kidney disease and determination of upper reference limit

in Thoracic Oncology

Qiang Miao
Bei Cai
Qian Niu
Junlong Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.1072531

2,570 views
6 citations

Original Research

Published on 08 Dec 2022

The prognosis analysis of organ metastatic patterns in lung large cell neuroendocrine carcinoma: A population-based study

in Thoracic Oncology

Kai Chen
Peiling Dai
Jiangwei Ni
Yili Xiang
Lizhong Gu

Frontiers in Oncology

doi 10.3389/fonc.2022.1050800

2,563 views
6 citations

Case Report

Published on 07 Dec 2022

Small cell lung cancer transformation and tumor heterogeneity after sequential targeted therapy and immunotherapy in EGFR-mutant non-small cell lung cancer: A case report

in Thoracic Oncology

Meng-Hang Yang
Jia Yu
Chen-Lei Cai
Wei Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1029282

4,346 views
12 citations

Editorial

Published on 02 Dec 2022

Editorial: Insights in thoracic oncology: 2021/2022

in Thoracic Oncology

Kaushal Parikh
Alfredo Addeo

Frontiers in Oncology

doi 10.3389/fonc.2022.1089540

4,729 views

Original Research

Published on 02 Dec 2022

Diagnostic value of dual-layer spectral detector CT in differentiating lung adenocarcinoma from squamous cell carcinoma

in Thoracic Oncology

Ronghua Mu
Zhuoni Meng
Zixuan Guo
Xiaoyan Qin
Guangyi Huang
Xuri Yang
Hui Jin
Peng Yang
Meimei Deng
Xiaodi Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.868216

3,774 views
13 citations

Case Report

Published on 01 Dec 2022

Case Report: A case of radioactive iodine-refractory thyroid cancer accompanying cervical lymph node metastasis treated with US-guided RFA combined with 125I seed implantation

in Thoracic Oncology

Yuanpeng Zhai
Yu Shao
Qian Li

Frontiers in Oncology

doi 10.3389/fonc.2022.987484

2,577 views
1 citation

Original Research

Published on 01 Dec 2022

Development and validation a simple scoring system to identify malignant pericardial effusion

in Thoracic Oncology

Xiaxia Jin
Lingling Hu
Meidan Fang
Qiaofei Zheng
Yuan Yuan
Guoguang Lu
Tao Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1012664

2,808 views
4 citations

Original Research

Published on 30 Nov 2022

The combination of a seven-autoantibody panel with computed tomography scanning can enhance the diagnostic efficiency of non-small cell lung cancer

in Thoracic Oncology

Tianyu He
Ziheng Wu
Pinghui Xia
Weidong Wang
Hua Sun
Li Yu
Wang Lv
Jian Hu

Frontiers in Oncology

doi 10.3389/fonc.2022.1047019

2,958 views
6 citations

1,911 articles

articles

Investigation of M2 macrophage-related gene affecting patients prognosis and drug sensitivity in non-small cell lung cancer: Evidence from bioinformatic and experiments

Study protocol of an open-label prospective phase II umbrella study of precise neoadjuvant therapy for patients with stage II-IIIB resectable non-small cell lung cancer (PURPOSE)

Whole exome sequencing in Chinese mucinous pulmonary adenocarcinoma uncovers specific genetic variations different from lung adenocarcinoma

Case report: Liquid biopsy, the sooner the better?

Corrigendum: Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis

Metabolic targeting, immunotherapy and radiation in locally advanced non-small cell lung cancer: Where do we go from here?

Low-dose computed tomography for lung cancer screening in Anhui, China: A randomized controlled trial

Next-generation sequencing of homologous recombination genes could predict efficacy of platinum-based chemotherapy in non-small cell lung cancer

Current status and challenges of immunotherapy in ALK rearranged NSCLC

Case Report: Bronchial artery embolization and chemoradiotherapy for central squamous cell lung carcinoma with rapid regression

Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy

Economic evaluation of first-line sugemalimab plus chemotherapy for metastatic non-small cell lung cancer in China

Corrigendum: Long non-coding RNA-TMPO-AS1 as ceRNA binding to let-7c-5p upregulates STRIP2 expression and predicts poor prognosis in lung adenocarcinoma

Editorial: Long non-coding RNAs in lung cancer

The natural growth history of persistent pulmonary subsolid nodules: Radiology, genetics, and clinical management

Current and novel therapeutic strategies for optimizing immunotherapy outcomes in advanced non-small cell lung cancer

Changes in lung cancer-related serum tumor markers in patients with chronic kidney disease and determination of upper reference limit

The prognosis analysis of organ metastatic patterns in lung large cell neuroendocrine carcinoma: A population-based study

Small cell lung cancer transformation and tumor heterogeneity after sequential targeted therapy and immunotherapy in EGFR-mutant non-small cell lung cancer: A case report

Editorial: Insights in thoracic oncology: 2021/2022

Diagnostic value of dual-layer spectral detector CT in differentiating lung adenocarcinoma from squamous cell carcinoma

Case Report: A case of radioactive iodine-refractory thyroid cancer accompanying cervical lymph node metastasis treated with US-guided RFA combined with 125I seed implantation

Development and validation a simple scoring system to identify malignant pericardial effusion

The combination of a seven-autoantibody panel with computed tomography scanning can enhance the diagnostic efficiency of non-small cell lung cancer